These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36225387)

  • 1. On the Relationship between Speech Intelligibility and Fluency Indicators among English-Speaking Individuals with Parkinson's Diseases.
    Liu CT; Chu SW; Chen YS
    Behav Neurol; 2022; 2022():1224680. PubMed ID: 36225387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cross-Language Study of Acoustic Predictors of Speech Intelligibility in Individuals With Parkinson's Disease.
    Kim Y; Choi Y
    J Speech Lang Hear Res; 2017 Sep; 60(9):2506-2518. PubMed ID: 28821018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of speaking task on intelligibility in Parkinson's disease.
    Tjaden K; Wilding G
    Clin Linguist Phon; 2011 Feb; 25(2):155-68. PubMed ID: 20887216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptual measures of speech from individuals with Parkinson's disease and multiple sclerosis: intelligibility and beyond.
    Sussman JE; Tjaden K
    J Speech Lang Hear Res; 2012 Aug; 55(4):1208-19. PubMed ID: 22232396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of speech task on intelligibility in dysarthria: a case study of Parkinson's disease.
    Kempler D; Van Lancker D
    Brain Lang; 2002 Mar; 80(3):449-64. PubMed ID: 11896652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acoustic vowel analysis and speech intelligibility in young adult Hebrew speakers: Developmental dysarthria versus typical development.
    Carl M; Icht M
    Int J Lang Commun Disord; 2021 Mar; 56(2):283-298. PubMed ID: 33522087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear Speech Variants: An Investigation of Intelligibility and Speaker Effort in Speakers With Parkinson's Disease.
    Stipancic KL; van Brenk F; Kain A; Wilding G; Tjaden K
    Am J Speech Lang Pathol; 2022 Nov; 31(6):2789-2805. PubMed ID: 36327495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers With Parkinson's Disease.
    Moya-Galé G; Goudarzi A; Bayés À; McAuliffe M; Bulté B; Levy ES
    Am J Speech Lang Pathol; 2018 Feb; 27(1):154-165. PubMed ID: 29351354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intelligibility Across a Reading Passage: The Effect of Dysarthria and Cued Speaking Styles.
    van Brenk F; Stipancic K; Kain A; Tjaden K
    Am J Speech Lang Pathol; 2022 Jan; 31(1):390-408. PubMed ID: 34982941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A serious game for speech training in dysarthric speakers with Parkinson's disease: Exploring therapeutic efficacy and patient satisfaction.
    Ganzeboom M; Bakker M; Beijer L; Strik H; Rietveld T
    Int J Lang Commun Disord; 2022 Jul; 57(4):808-821. PubMed ID: 35338751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and pattern of perceived intelligibility changes in Parkinson's disease.
    Miller N; Allcock L; Jones D; Noble E; Hildreth AJ; Burn DJ
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1188-90. PubMed ID: 17400592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Intelligibility Gains in Dysarthria Through Automated Speech Feature Analysis.
    Fletcher AR; Wisler AA; McAuliffe MJ; Lansford KL; Liss JM
    J Speech Lang Hear Res; 2017 Nov; 60(11):3058-3068. PubMed ID: 29075755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acoustic and perceptual correlates of faster-than-habitual speech produced by speakers with Parkinson's disease and multiple sclerosis.
    Kuo C; Tjaden K; Sussman JE
    J Commun Disord; 2014; 52():156-69. PubMed ID: 25287378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
    Vásquez-Correa JC; Orozco-Arroyave JR; Bocklet T; Nöth E
    J Commun Disord; 2018; 76():21-36. PubMed ID: 30149241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intelligibility of dysarthric speech: perceptions of speakers and listeners.
    Walshe M; Miller N; Leahy M; Murray A
    Int J Lang Commun Disord; 2008; 43(6):633-48. PubMed ID: 18608608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech treatment for Hebrew-speaking adolescents and young adults with developmental dysarthria: A comparison of mSIT and Beatalk.
    Carl M; Levy ES; Icht M
    Int J Lang Commun Disord; 2022 May; 57(3):660-679. PubMed ID: 35363414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acoustic characteristics in relation to intelligibility reduction in noise for speakers with Parkinson's disease.
    Chiu Y; Neel A; Loux T
    Clin Linguist Phon; 2021 Mar; 35(3):222-236. PubMed ID: 32539544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acoustic variation during passage reading for speakers with dysarthria and healthy controls.
    Kuo C; Tjaden K
    J Commun Disord; 2016; 62():30-44. PubMed ID: 27219893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.